key: cord-0030027-tmd3errl
authors: Vasunilashorn, Sarinnapha M.; Fong, Tamara G.; Helfand, Benjamin K. I.; Hshieh, Tammy T.; Marcantonio, Edward R.; Metzger, Eran D.; Schmitt, Eva M.; Tabloski, Patricia A.; Travison, Thomas G.; Gou, Yun; Jones, Richard N.; Inouye, Sharon K.
title: Psychometric Properties of a Delirium Severity Score for Older Adults and Association With Hospital and Posthospital Outcomes
date: 2022-03-31
journal: JAMA Netw Open
DOI: 10.1001/jamanetworkopen.2022.6129
sha: 785d3e57aea1474cf22bffa151403d30adf917a5
doc_id: 30027
cord_uid: tmd3errl

IMPORTANCE: The ability to rate delirium severity is key to providing optimal care for older adults, and such ratings would allow clinicians to target patients with severe delirium and monitor response to treatment, recovery time, and prognosis; assess nursing burden and staffing needs; and, ultimately, provide more appropriate patient-centered care. Current delirium severity measures have been limited in their content, gradations, and measurement characteristics. OBJECTIVE: To examine the internal consistency, reliability, and validity for clinical outcomes of the DEL-S delirium severity score, a measure of delirium severity that was developed using advanced psychometric approaches, analogous to those of the Patient-Reported Outcomes Measurement Information System initiative. DESIGN, SETTING, AND PARTICIPANTS: This prospective cohort study was conducted at a large academic medical center in Boston, Massachusetts. Adults aged 70 years or older who were admitted or transferred to medical or surgical services as either emergency or elective admissions were enrolled between October 20, 2015, and March 15, 2017, and were monitored for 1 year. Data analysis was performed from June 2020 to August 2021. EXPOSURES: Delirium severity, measured by scores on the delirium severity score short-form (SF; 6 items, scored 0-13, with higher scores indicating more severe delirium) and long-form (LF; 17 items, scored 0-21), considered continuously and grouped into 5 categories. MAIN OUTCOMES AND MEASURES: The primary outcomes were in-hospital outcomes, including length of stay and hospital costs, and posthospital (30, 90, and 365 days) outcomes, including death, health care costs, and rehospitalization. RESULTS: The 352 participants had a median (IQR) age of 79.7 (74.6-85.5) years, 204 (58.0%) were women, and they were highly educated (median [IQR] duration of education, 14 [7-20] years). Patients in the highest delirium severity score SF group (scores 6-9) had a longer length of stay (13.3 vs 6.9 days; P for trend < .001), greater in-hospital costs ($57 700 vs $34 200), greater cumulative health care costs ($168 700 vs $106 500; P for trend = .01), and increased mortality at 1 year (50% vs 17%; P for trend = .02) compared with patients in the lowest delirium severity score SF group (score 0). Similar trends and significant findings were demonstrated for the delirium severity score LF. CONCLUSIONS AND RELEVANCE: These findings suggest that the delirium severity score provides an approach for measuring delirium severity that is associated with adverse clinical outcomes in a direct exposure-response association and that the delirium severity score may help advance patient-centered care for delirium.

The manuscript reports "fold-difference" effect size statistics (we don't use the more commonly encountered language "fold-change" because we are describing group differences, not changes). The fold-difference is computed after regression models and reflect adjustment for covariates and missing data handling. The fold-difference is computed, generally, as the expected value among persons in the highest severity category divided by the expected value among persons in the lowest severity category, with covariates held at their overall sample means. This is, in general, (b0 + b4)/b0 where b0 is the regression model constant term (the expected value in the reference group, as all covariates are mean centered) and b4 is the regression parameter associated with being in the highest category of severity. An alternative form is exp(b0 + b4)/exp(b0) for outcomes that are modeled on a log scale (including Poisson [length of stay] and log normal [costs] out-comes). interval estimates are obtained using the Delta method.

Here we explain how this works. First, consider the length of stay variable according to levels of severity on the long form of the DELS:

. The mean length of stay in the high severity group (12.103) is 1.699 times the mean length of stay in the low severity group (7.125). If we look at a regression model comparing length of stay controlling for our select covariates:

. In all cases, missing data in outcome variables was addressed with inverse propensity weighting. This means the probability of being missing on the outcome was modeled (using logistic regression) and the same predictors (including DEL-S) and the baseline value of the outcome used as predictors according to the main analysis model. The model was used to generate predicted prob-abilities of missing on the outcome given baseline and covariates, which were converted to inverse propensity weights using actual missingness. The inverse propensity weights were scaled to the total sample size among those non-missing on the outcome, and used to weight the sample before assessing the strength of association with the DEL-S. Please see Seaman & White (2013) for a discussion of the approach. 

This section describes categorization of delirium severity using the DEL-S using the distribution of daily DEL-S scores. Therefore, this categorization is indifferent to peak and sums. The point is to arrive at a categorization that can be interpreted at the bedside, not after discharge.

Participants are grouped into five levels of severity according to both instruments. The five levels of severity are defined as:

DELS cat level DELS6 sums DELS17 sums Threshold definition 0 0 0 No DELS symptoms (sum score is 0) 1 1 1 DELS sum is not 0 but less than minimum among CAM delirium positive 2 2 -3 2 -4 DELS sum is in the lower third among CAM delirium positive 3 4 -5 5 -6 DELS sum is in the middle third among CAM delirium positive 4 6 -9 7 -14 DELS score is in the top third among CAM delirium positive 

Total Health Care Costs of Index Hospitalization Data note. See Gou et al (2020, submitted) for details on source and description of costs data.

Methods note. We use a generalized linear model with log link to characterize total costs as a function of peak DELS severity during the hospital stay. We include age, sex, race/ethnicity, and Dementia or MCI at time of enrollment as potentially confounding variables. Effects of percentile rank normalized delirium severity are expressed for every 2 SD difference, following the recommendations of Gelman (2008) .

These analyses are adjusted for age, sex, race, and cognitive impairment.

Results: These analyses make use of 299 observations with evaluable cost data. We used inverse propensity weights to account for missingness.

For peak score during hospitalization, each 2 standard deviation difference was associated with significantly increased costs: 2019USD 8,100 (95% CI: 2,200 -13,900), after accounting for the effect of sex, race/ethnicity, age, and baseline cognitive impairment (f2 = 0.001 P=.01). Fold difference: The expected costs were 1.705 times as much for those in the highest severity category relative to the lowest severity category (95% confidence interval 0.86, 2.55).

For peak score during hospitalization, each 2 standard deviation difference was associated with significantly increased costs: 2019USD 8,900 (95% CI: 3,400 -14,400), after accounting for the effect of sex, race/ethnicity, age, and baseline cognitive impairment (f2 = 0.001 P=.004). Fold difference: The expected costs were 2.025 times as much for those in the high-est severity category relative to the lowest severity category (95% confidence interval 1.06, 2.99). Cumulative healthcare costs to 1 year Methods note. We use a generalized linear model with log link to characterize total costs as a function of peak DELS severity during the hospital stay. We include age, sex, race/ethnicity, and Dementia or MCI at time of enrollment as potentially confounding variables. Effects of percentile rank normalized delirium severity are expressed for every 2 SD difference, following the recommendations of Gelman (2008).

These analyses make use of 311 observations with evaluable cost data. We used inverse propensity weights to account for missingness.

Longform: For peak score during hospitalization, each 2 standard deviation difference was associated with significantly increased costs over 1 year: 2019USD 17,000 (95% CI: 1,900 -32,100), after ac-counting for the effect of sex, race/ethnicity, age, and baseline cognitive impairment (f2 = 0.001 P=.03). Fold difference: The expected costs were 1.665 times as much for those in the highest severity category relative to the lowest severity category (95% confidence interval 0.96, 2.37).

For peak score during hospitalization, each 2 standard deviation difference was associated with significantly increased costs over 1 year: 2019USD 20,000 (95% CI: 5,300 -34,700), after ac-counting for the effect of sex, race/ethnicity, age, and baseline cognitive impairment (f2 = 0.001 P=.01). Fold difference: The expected costs were 1.755 times as much for those in the high-est severity category relative to the lowest severity category (95% confidence interval 1.05, 2.46). Cumulative healthcare costs to 30 days Methods note. We use a generalized linear model with log link to characterize total costs as a function of peak DELS severity during the hospital stay. We include age, sex, race/ethnicity, and Dementia or MCI at time of enrollment as potentially confounding variables. Effects of percentile rank normalized delirium severity are expressed for every 2 SD difference, following the recommendations of Gelman (2008) . These analyses are adjusted for age, sex, race, and cognitive impairment.

These analyses make use of 308 observations with evaluable cost data. We used inverse propensity weights to account for missingness.

Long form: For peak score during hospitalization, each 2 standard deviation difference was associated with significantly increased costs over 1 year: 2019USD 2,100 (95% CI: 0 -4,200), after accounting for the effect of sex, race/ethnicity, age, and baseline cognitive impairment (f2 = 0.001 P=.06). Fold difference: The expected costs were 2.021 times as much for those in the highest severity category relative to the lowest severity category (95% confidence interval 0.78, 3.26).

For peak score during hospitalization, each 2 standard deviation difference was associated with significantly increased costs over 1 year: 2019USD 2,400 (95% CI: 400 -4,400), after accounting for the effect of sex, race/ethnicity, age, and baseline cognitive impairment (f2 = 0.001 P=.03). Fold difference: The expected costs were 1.763 times as much for those in the highest severity category relative to the lowest severity category (95% confidence interval 0.62, 2.90). 

Methods note. We use Poisson regression with robust variance estimation to characterize the risk of Any rehospitalization within 90 days as a function of of peak DELS severity during the hospital stay. We include age, sex, race/ethnicity, and Dementia or MCI at time of enrollment as potentially confounding variables. Effects of percentile rank normalized delirium severity are expressed for every 2 SD difference, following the recommendations of Gelman (2008) .

These analyses made use of 352 participants. Of these, 119 ( 34%) participants had Any rehospitalization within 90 days. We used inverse propensity weights to account for missingness. 

Methods note. We use Poisson regression with robust variance estimation to characterize the risk of Any rehospitalization within 365 days as a function of peak DELS severity during the hospital stay. We include age, sex, race/ethnicity, and Dementia or MCI at time of enrollment as potentially confounding variables. Effects of percentile rank normalized delirium severity are expressed for every 2 SD difference, following the recommendations of Gelman (2008) .

These analyses made use of 352 participants. Of these, 197 (56%) participants had Any rehospitalization within 365 days. We used inverse propensity weights to account for missingness.

Long Form: For DELS (long form) peak score during hospitalization, each 2 standard deviation difference was associated with significantly increased risk of Any rehospitalization within 365 days: relative risk 1.12 (95% Confidence Interval: 0.94 -1.34, P = .19). Fold difference: The expected costs were 1.286 times as much for those in the highest severity category relative to the lowest severity category (95% confidence interval 0.60, 1.97).

For DELS (short form) peak score during hospitalization, each 2 standard deviation difference was associated with significantly increased risk of Any rehospitalization within 365 days: relative risk 1.12 (95% Confidence Interval: 0.94 -1.35, P = .21). Fold difference: The expected costs were 1.231mes as much for those in the highest severity category relative to the lowest severity category (95% confidence interval 0.56, 1.90). 

Methods note. We use Poisson regression with robust variance estimation to characterize the risk of death within 30 days as a function of peak DELS severity during the hospital stay. We include age, sex, race/ethnicity, and Dementia or MCI at time of enrollment as potentially confounding variables. Effects of percentile rank normalized delirium severity are expressed for every 2 SD difference, following the recommendations of Gelman (2008) .

These analyses made use of 352 participants. Of these, 20 (6%) participants died by the one month follow-up. 

Methods note. We use Poisson regression with robust variance estimation to characterize the risk of death within 30 days as a function of peak DELS severity during the hospital stay. We include age, sex, race/ethnicity, and Dementia or MCI at time of enrollment as potentially confounding variables. Effects of percentile rank normalized delirium severity are expressed for every 2 SD difference, following the recommendations of Gelman (2008) .

These analyses made use of 352 participants. Of these, 92 (26.1%) participants died by one year follow-up.

Long Form: For DELS (long form) peak score during hospitalization, each 2 standard deviation difference was associated with significantly increased risk of death by 365 days: relative risk 1.48 (95% Confidence Interval: 1.03 -2.11, P = .03). The risk of death was 2.740 for those in the highest severity category relative to the lowest severity category (95% confidence interval 0.13, 5.35; P = .04).

For DELS (short form) peak score during hospitalization, each 2 standard deviation difference was associated with significantly increased risk of death by 365 days: relative risk 1.55 (95% Confidence Interval: 1.08 -2.22, P = .02). The risk of death was 3.666 for those in the highest severity category relative to the lowest severity category (95% confidence interval 0.06, 7.28; P = .046). 

Statistical power analysis for the behavioral sciences

Scaling regression inputs by dividing by two standard deviations

One-Year Medicare Costs Associated with Delirium in Older Patients Undergoing Major Elective Surgery

for the, BASIL Study Group

Test Theory: A Unified Treatment

Psychometric theory

Review of inverse probability weighting for dealing with missing data

New Delirium Severity Indicators: Generation and Internal Validation in the Better Assessment of Illness (BASIL) Study